ConductScience.org, home

Paper283262

A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line.

Pathak S and 4 others. J Natl Cancer Inst, 1979. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line. Papers, record 283262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/283262

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1979
PubMed
Publication types
Case Reports, Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2022-03-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pathak SS
2Siciliano MJM J
3Cailleau RR
4Wiseman CLC L
5Hsu TCT C

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Breast NeoplasmsMajor topic
Chromosome AberrationsMajor topic
Chromosomes, Human, 1-3Major topic
HeLa CellsMajor topic
IsoenzymesMajor topic
Cell Line
Female
Glucosephosphate Dehydrogenase
Humans
Middle Aged
Neoplasms, Experimental

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
30363973Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines.Int J Breast Cancer2018https://conductscience.org/library/papers/30363973PubMed
28808525Anticancer metallohelices: nanomolar potency and high selectivity.Chem Sci2016https://conductscience.org/library/papers/28808525PubMed
27447733Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.J Proteome Res2016https://conductscience.org/library/papers/27447733PubMed
24196532Do you know the sex of your cells?Am J Physiol Cell Physiol2014https://conductscience.org/library/papers/24196532PubMed
22859737Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.Exp Biol Med (Maywood)2012https://conductscience.org/library/papers/22859737PubMed
6988327A molecular approach to the identification and individualization of human and animal cells in culture: isozyme and allozyme genetic signatures.In Vitro1980https://conductscience.org/library/papers/6988327PubMed
3978245Development of a new human breast cancer cell line Ia-270.Breast Cancer Res Treat1985https://conductscience.org/library/papers/3978245PubMed
3494191Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants.Mol Cell Biol1987https://conductscience.org/library/papers/3494191PubMed
3308827Genetic predisposition to cancer with special reference to mutagen sensitivity.In Vitro Cell Dev Biol1987https://conductscience.org/library/papers/3308827PubMed
3185547Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.Mol Cell Biol1988https://conductscience.org/library/papers/3185547PubMed
2537620Activation of the Na+/H+ antiport is not required for epidermal growth factor-dependent gene expression, growth inhibition or proliferation in human breast cancer cells.Biochem J1989https://conductscience.org/library/papers/2537620PubMed
2182210Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity.Cancer Metastasis Rev1990https://conductscience.org/library/papers/2182210PubMed
730202Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.In Vitro1978https://conductscience.org/library/papers/730202PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/283262

GET https://conductscience.org/api/papers/v1/283262/authors